[Taxol and ovarian adenocarcinomas].
Marty
M
M
Service d'Oncologie Médicale, Hôpital Saint-Louis, Paris, France.
Extra
J M
JM
Culine
S
S
Rousseau
F
F
D000230:Adenocarcinoma / Q000188:drug therapy*; D000470:Alkaloids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel
D000470:Alkaloids; D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel
Taxol et adénocarcinomes ovariens.